LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news FMC Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ModivCare Inc. ("ModivCare" or "the Company") (NASDAQ:MODV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 3, 2022, and September 15, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.

image for news ModivCare Inc. Is Being Sued For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S ("Novo" or "the Company") (NYSE:NVO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 02, 2022 and December 19, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.

image for news The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Novo Nordisk A/S

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE:GSK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.

image for news GSK plc Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Flex Ltd. ("Flex" or "the Company") (NASDAQ:FLEX) for violations of the securities laws.

image for news The Schall Law Firm Invites Shareholders With Losses In Flex Ltd. To Join A Securities Fraud Investigation

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vail Resorts, Inc. ("Vail Resorts" or "the Company") (NYSE:MTN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news The Schall Law Firm Invites Shareholders With Losses In Vail Resorts, Inc. To Join A Securities Fraud Investigation

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Napco Security Technologies, Inc. ("Napco" or "the Company") (NASDAQ:NSSC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news The Schall Law Firm Invites Shareholders With Losses In Napco Security Technologies, Inc. To Join A Securities Fraud Investigation

LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

image for news FTAI Aviation Ltd. Is Being Sued For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

PHILADELPHIA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of Monolithic Power Systems, Inc. (NASDAQ: MPWR) shareholders. The investigation concerns whether certain officers and directors of Monolithic have breached their fiduciary duties owed to the company.

image for news Long-Term Monolithic Power Systems, Inc. (Nasdaq: MPWR) Shareholders are Encouraged to Contact Grabar Law Office

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term — Positive

DGX   Zacks Investment Research — February 10, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

EnerSys (ENS) is a Top-Ranked Momentum Stock: Should You Buy? — Positive

ENS   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news EnerSys (ENS) is a Top-Ranked Momentum Stock: Should You Buy?

Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term — Positive

ENSG   Zacks Investment Research — February 10, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term

Why Clearway Energy (CWEN) is a Top Momentum Stock for the Long-Term — Positive

CWEN   Zacks Investment Research — February 10, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Why Clearway Energy (CWEN) is a Top Momentum Stock for the Long-Term

Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock — Positive

RCL   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock

Here's Why Logitech (LOGI) is a Strong Momentum Stock — Positive

LOGI   Zacks Investment Research — February 10, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why Logitech (LOGI) is a Strong Momentum Stock

What to Expect From Service Corporation in Q4 Earnings Release? — Positive

SCI   Zacks Investment Research — February 10, 2025

SCI's Q4 results are likely to reflect gains from a resilient business model and favorable demographics.

image for news What to Expect From Service Corporation in Q4 Earnings Release?

Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet — Positive

RGNX   Zacks Investment Research — February 10, 2025

The consensus price target hints at a 333% upside potential for Regenxbio (RGNX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet

The mean of analysts' price targets for Revolution Medicines (RVMD) points to a 74.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect?

Hercules Capital: Hybrid Strategy Crafts A BDC Winner — Positive

HTGC   Seeking Alpha — February 10, 2025

Hercules Capital brings a conservative yet flexible BDC strategy and a focus on innovative companies as dealmaking targets. The leadership team boasts extensive and varied financial experience. Its track record should create confidence for investors. Hercules' business strategy is based on a selective approach to dealmaking, consistent liquidity maintenance and flexible loan structuring fit to target company situations.

image for news Hercules Capital: Hybrid Strategy Crafts A BDC Winner

The mean of analysts' price targets for Central Garden (CENTA) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Predict a 26.6% Upside in Central Garden (CENTA): Here's What You Should Know